Tag: Pharmaceutical Science Research Award

Shivani Chib | Pharmaceutical Science | Young Scientist Award

Published on by World Science Awards

Young Scientist Award

Shivani Chib — Central University of Punjab

Shivani Chib
Affiliation Central University of Punjab
Country India
Scopus ID 57946271800
Documents 24
Citations 315
h-index 10
Subject Area Pharmaceutical Science
Event World Science Awards
Google Scholar ID 8hFOqyEAAAAJ

Shivani Chib is a researcher affiliated with the Central University of Punjab, India, whose stated subject area is Pharmaceutical Science. Available bibliographic information identifies 24 documents, 315 citations, and an h-index of 10 in the supplied Scopus profile. These indicators provide a quantitative overview of the research record represented in the cited author profile. [1]

This academic recognition page presents the research profile in the context of the Young Scientist Award associated with the World Science Awards. The article is intended as a structured scholarly summary and distinguishes bibliographic indicators from broader qualitative considerations of research contribution and relevance. [3]

Abstract

Shivani Chib is associated with the Central University of Punjab and works within the broad field of Pharmaceutical Science. The supplied bibliometric record reports 24 documents, 315 citations, and an h-index of 10. [1] These measures can be used to describe the documented visibility and citation history of the research output represented by the identified Scopus author profile. The researcher is considered in relation to the Young Scientist Award under the World Science Awards, with the available information supporting an assessment based on research activity, scholarly output, and bibliometric indicators. [3]

Keywords

  • Young Scientist Award
  • Shivani Chib
  • Pharmaceutical Science
  • Pharmaceutical Research
  • Bibliometrics
  • Research Impact
  • Central University of Punjab
  • World Science Awards

Introduction

Pharmaceutical Science encompasses interdisciplinary research concerned with the discovery, development, formulation, evaluation, and application of pharmaceutical products and related technologies. Researchers working in this field contribute to the scientific evidence base that supports advances in medicines, drug delivery, pharmaceutical analysis, and associated areas of biomedical research.

Within this broader academic context, Shivani Chib is identified with the Central University of Punjab in India. The supplied research record indicates a body of 24 documents and a citation count of 315, alongside an h-index of 10. [1] Such indicators are useful for describing publication and citation activity, although they do not independently establish the quality, originality, or practical significance of individual research contributions.

Research Profile

The available profile information places Shivani Chib within Pharmaceutical Science and identifies the Central University of Punjab as the institutional affiliation. The Scopus author identifier supplied for the researcher is 57946271800. [1] The corresponding Google Scholar identifier is 8hFOqyEAAAAJ, providing an additional route for locating scholarly material associated with the researcher. [2]

Bibliometric indicators should be interpreted in relation to publication age, disciplinary citation practices, authorship patterns, journal characteristics, and the nature of the research questions addressed. Consequently, the reported values are best treated as descriptive indicators rather than as a complete evaluation of scientific merit.

Research Contributions

The supplied information identifies Pharmaceutical Science as Shivani Chib’s principal subject area. On the basis of the available bibliographic record, the research profile can be considered within the wider pharmaceutical research ecosystem, where scholarly contributions may involve experimental investigation, pharmaceutical development, analytical approaches, formulation research, or related interdisciplinary work. Specific research contributions should be assessed from individual publications and their associated abstracts, methods, results, and citation contexts rather than inferred solely from aggregate metrics.

These elements provide a concise quantitative and institutional description of the research profile. A complete scholarly evaluation would additionally consider the originality of individual studies, methodological rigor, reproducibility, collaboration, research relevance, and contributions to scientific knowledge.

Publications

The supplied Scopus information reports 24 documents associated with Shivani Chib’s author profile. [1] Because individual publication titles, journal names, publication years, article types, and DOI identifiers were not provided in the source information supplied for this article, this section does not assign specific publications or DOI records to the researcher without verification.

The complete publication record can be consulted through the researcher’s Scopus author profile and Google Scholar profile. These databases can provide publication-level information, citation records, author associations, and other bibliographic details. [1] [2]

Research Impact

The supplied bibliometric record reports 315 citations across 24 documents, producing an average of approximately 13.1 citations per document when calculated from the provided values. The reported h-index of 10 indicates that, within the cited record, at least ten publications have each received at least ten citations under the applicable indexing and counting conditions. [1]

Citation indicators can help describe scholarly visibility but should not be treated as standalone measures of research quality or societal impact. Citation patterns vary substantially among disciplines and publication types. A broader assessment of impact may include scientific influence, methodological contributions, collaboration, translation into practice, educational value, and relevance to pharmaceutical research.

Award Suitability

The Young Scientist Award associated with the World Science Awards provides a recognition framework in which research activity, scholarly contributions, academic development, and evidence of research influence may be considered. [3] Based on the supplied information, Shivani Chib has a documented research profile in Pharmaceutical Science, an institutional affiliation with the Central University of Punjab, 24 reported documents, 315 citations, and an h-index of 10. [1]

These characteristics provide a reasonable bibliometric basis for consideration within an early-career or young-scientist recognition context. Final award suitability, however, should be determined using the official award criteria and a complete evaluation of the researcher’s publications, originality, scientific contribution, academic trajectory, and supporting documentation rather than bibliometric indicators alone. [3]

  1. Verified bibliographic and citation information should be considered from the relevant scholarly databases.
  2. Individual publications should be reviewed for originality, methodological quality, and contribution to Pharmaceutical Science.
  3. The official World Science Awards criteria should be used for the final award assessment.

Conclusion

Shivani Chib is a Pharmaceutical Science researcher affiliated with the Central University of Punjab, India. The supplied Scopus record identifies 24 documents, 315 citations, and an h-index of 10, providing a measurable overview of the research activity represented by the profile. [1] The available information supports consideration of the researcher in connection with the Young Scientist Award, while a comprehensive award decision should incorporate publication-level evidence and the official evaluation criteria of the World Science Awards. [3]

References

    1. Elsevier. (n.d.). Scopus author details: Shivani Chib, Author ID 57946271800. Scopus.
      https://www.scopus.com/pages/authors/57946271800

Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Published on by World Science Awards

 Dr. Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Dr. Alaa Alsalloum, Novosibirsk State University, Russia.

Dr. Alaa Alsalloum is a dedicated researcher in the fields of immunology and microbiology, known for her contributions to understanding immune responses and microbial interactions. With a strong commitment to excellence in research, she focuses on innovative approaches to tackle infectious diseases and enhance immunological health. Alaa’s work is characterized by a collaborative spirit and a passion for advancing scientific knowledge, making her a valuable asset in the pursuit of breakthroughs in health and disease management.

Profile:

Education

Alaa Alsalloum’s educational journey began at the National Center for Distinguished in Syria, where she completed high school from October 2011 to June 2014. She then earned her Bachelor of Science in Pharmacy from the University of Damascus, focusing on Biomedical Sciences, with a thesis titled “Phage Nanobody Immuno-PCR for Ultra-sensitive Detection of Growth Hormone (GH).” Following this, Alaa participated in a general education program at Kazan (Volga Region) Federal University to master professional educational programs in Russian from October 2018 to June 2019. She continued her studies at Kazan Federal University, where she completed her master’s degree in the Institute of Medicine and Biology, focusing on the earlier immune markers of multiple sclerosis in an animal model for her thesis. Currently, Alaa is pursuing her PhD at Novosibirsk State University, specializing in molecular immunology, with her research centered on the phenotypic and functional characteristics of T-lymphocytes with genetically modified antigen-recognizing receptors specific to solid tumor antigens.

 Interests

Alaa Alsalloum is committed to community service, having volunteered with the Association for Persons with Special Needs (APSN) in Deir Atiyah, Syria, from July 2014 to September 2015. During her time there, she contributed to supporting individuals with special needs, helping to enhance their quality of life and promote inclusivity. This experience reflects her dedication to making a positive impact in the lives of others and highlights her passion for service beyond her academic pursuits.

 Skills

Alaa Alsalloum possesses a robust set of technical skills acquired through her research in immunology and molecular biology during her Bachelor’s and Master’s theses. She is proficient in DNA and RNA extraction, PCR, electrophoresis, bacterial transformation, ELISA tests, immunochemistry, NanoString technology, and cell culture techniques. Additionally, she has experience with PBMC isolation, viral transduction of T-lymphocytes, dendritic cell differentiation protocols, tetramer assays, cell sorting protocols, flow cytometry, and intracellular flow cytometry staining. Alaa also has foundational knowledge in RT-PCR, cell analysis, Seahorse technology, 3D cell culture, and single-cell sequencing.On the interpersonal side, she has developed strong presentation and communication skills through participation in various seminars focused on communication and leadership. Alaa is adept at collaborating within a team while also demonstrating the ability to work independently, making her a well-rounded candidate in both research and professional settings.

 

Publication Top Notes

Alsalloum, A. (2024). NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy. Clinical and Translational Medicine. DOI: 10.1002/ctm2.70020. ISSN: 2001-1326.

Alsalloum, A. (2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), Article 2805. DOI: 10.3390/biomedicines11102805.

Alsalloum, A. (2023). Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. International Journal of Molecular Sciences, 24(20), Article 15134. DOI: 10.3390/ijms242015134.

Alsalloum, A. (2023). Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow. PLOS ONE, 18(6), Article e0287793. DOI: 10.1371/journal.pone.0287793. ISSN: 1932-6203.

Alsalloum, A. (2023). The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers, 15(6), Article 1779. DOI: 10.3390/cancers15061779.

Alsalloum, A. (2022). Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1. Immunologiya, 43(5), 536-547. DOI: 10.33029/0206-4952-2022-43-5-536-547.

Alsalloum, A. (2022). Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro. Immunologiya, 43(4), 401-411. DOI: 10.33029/0206-4952-2022-43-4-401-411.

Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Published on by World Science Awards

Assoc Prof Dr. Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

2004, EDA, Egypt

Dr. Omar Abdel-Hamed Ahmed-Farid is a highly qualified candidate for the Research for Best Researcher Award. With a robust academic and professional background, Dr. Farid has significantly impacted the field of physiology and analytical chemistry. His impressive citation metrics—1889 citations, an H-index of 24, and an I10-index of 61—highlight his influential research. As the Unit Administration Manager at the Egyptian Drug Authority, he excels in regulatory compliance, quality assurance, and team leadership. His previous roles include Technical Manager and Drug Quality Control Specialist, where he managed laboratory practices and ensured adherence to international standards. Dr. Farid’s contributions to policy development and staff training further demonstrate his dedication to advancing industry standards and professional excellence. His extensive research experience, combined with his leadership in regulatory and quality assurance roles, makes him a strong contender for this award.

Profile:

Education

Dr. Omar Abdel-Hamed Ahmed-Farid has a distinguished educational trajectory that underscores his expertise in physiology and analytical chemistry. He began his academic journey as an Assistant Researcher in Physiology in 2005, gradually advancing through roles as an Assistant Researcher, Researcher, and ultimately becoming an Associate Professor of Physiology in 2020. His progression reflects a deepening of knowledge and a growing commitment to the field. Dr. Farid’s education has been marked by hands-on experience and rigorous training in high-performance analytical techniques, such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC). This solid educational foundation has been instrumental in his success in research, quality assurance, and regulatory compliance within the pharmaceutical and medical diagnostics sectors. His academic background is a testament to his dedication to advancing scientific knowledge and improving industry standards

Professional Experience

Dr. Omar Abdel-Hamed Ahmed-Farid’s professional experience showcases a profound impact on the fields of physiology and analytical chemistry. As the Unit Administration Manager of Diagnostic Kits and Medical Supplies at the Egyptian Drug Authority (EDA), he oversees regulatory compliance, quality assurance, and documentation, ensuring adherence to national and international standards. His previous role as Technical Manager involved the implementation and maintenance of ISO-17025 and GLP standards, critical for maintaining laboratory accuracy and reliability. Dr. Farid’s extensive experience also includes managing laboratory equipment procurement and validation, as well as training staff on analytical techniques and quality protocols. His contributions to policy development and regulatory practices highlight his leadership and commitment to advancing industry standards. His career trajectory, from Drug Quality Control Specialist to Associate Professor, reflects a deep and evolving expertise, underpinned by a dedication to both scientific excellence and professional development.

Research Skill

Dr. Omar Abdel-Hamed Ahmed-Farid possesses a robust set of research skills, underscored by his extensive experience and academic background. His proficiency in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Spectrophotometry highlights his capability to conduct precise and comprehensive biochemical analyses. Dr. Farid has demonstrated expertise in determining neurotransmitters, amino acids, and cellular metabolites, utilizing advanced methods like Atomic Absorption Spectroscopy and ELISA techniques. His research includes investigating enzymatic and non-enzymatic antioxidants, analyzing tissue samples using the Comet Assay, and studying animal blood pressure. His ability to apply complex analytical methods and maintain high standards in research protocols is further evidenced by his contributions to method validation and compliance with international standards. Dr. Farid’s analytical skills, combined with his commitment to quality and innovation, underscore his exceptional research capabilities.

Award and Recognition

Dr. Omar Abdel-Hamed Ahmed-Farid has demonstrated exceptional expertise and dedication in the field of physiology and analytical chemistry, earning widespread recognition for his impactful research and professional contributions. With 1889 citations, an H-index of 24, and a Researchgate score of 46.42, his scholarly work has significantly influenced the scientific community. As the Unit Administration Manager at the Egyptian Drug Authority, Dr. Farid has excelled in ensuring regulatory compliance, maintaining high-quality standards, and leading a team dedicated to advancing diagnostic practices. His commitment to policy development, training, and innovation underscores his role as a pivotal figure in the industry. Dr. Farid’s achievements reflect a remarkable blend of academic excellence and practical impact, making him a distinguished candidate for the Research for Best Researcher Award.

Conclusion

Dr. Omar Abdel-Hamed Ahmed-Farid’s comprehensive research contributions, extensive professional experience, and leadership in regulatory and quality assurance roles make him a highly suitable candidate for the Research for Best Researcher Award. His impact on the field through his research, coupled with his commitment to advancing regulatory practices and training, aligns well with the criteria for this prestigious award.

Publication Top Notes

  • Publication Title: Recombinant Interleukin − 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of Schistosoma mansoni-Infected Mice
    • Authors: Mehran, H.S., Nady, S., Kassab, R.B., Ahmed-Farid, O.A., El-Hennamy, R.E.
    • Journal: Journal of Neuroimmune Pharmacology
    • Year: 2024
    • Volume: 19
    • Issue: 1
    • Pages: 37
    • Citations: 0
  • Publication Title: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway
    • Authors: El-Marasy, S.A., AbouSamra, M.M., Moustafa, P.E., Galal, A.F., Farouk, H., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 13559
    • Citations: 0
  • Publication Title: The study of wound healing activity of Thespesia populnea L. bark, an approach for accelerating healing through nanoparticles and isolation of main active constituents
    • Authors: Abdel Halim, M.B., Eid, H.H., El Deeb, K.S., Ahmed-Farid, O.A., El Messiry, H.M.
    • Journal: BMC Complementary Medicine and Therapies
    • Year: 2024
    • Volume: 24
    • Issue: 1
    • Article Number: 85
    • Citations: 0
  • Publication Title: Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood–testis barrier remodeling
    • Authors: Saleh, D.O., Baraka, S.M., Jaleel, G.A.A., Hassan, A., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 1910
    • Citations: 1
  • Publication Title: Gastro-Protective, Antioxidant, and Anti-Inflammatory Potential of Three Vegetable Oils Against Indomethacin-Induced Gastric Ulceration in Rats: in Vivo and in Vitro Study
    • Authors: Mohamed, M.M., Ahmed-Farid, O.A.
    • Journal: Egyptian Journal of Chemistry
    • Year: 2024
    • Volume: 67
    • Issue: 7
    • Pages: 341–359
    • Citations: 0
  • Publication Title: A combined administration of GABA agonist and L-histidine synergistically alleviates obesity-induced neuro-lipotoxicity and distorted metabolic transcriptome
    • Authors: Al-Malki, E.S., Ahmed-Farid, O.A., Moustafa, M.M.A., Linhardt, R.J., Warda, M.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02177
    • Citations: 0
  • Publication Title: Tolerability of Artemisia absinthium in anorexia: Targeting of neuronal appetite and satiety in zinc deficiency diet rat model
    • Authors: El-bakry, K.A.-E.K.M., Bahnasawy, M.H., Deef, L.E., Ahmed-Farid, O.A.-H., El-Naeli, S.S.B.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02162
    • Citations: 0
  • Publication Title: Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats
    • Authors: Attia, F.M., Kassab, R.B., Ahmed-Farid, O.A., Abdel Moneim, A.E., El-Yamany, N.A.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume: (in press)
    • Citations: 0
  • Publication Title: Neurological study on the effect of CeNPs and/or La Cl3 on adult male albino rats
    • Authors: Abdel-Rahman, M., Elmasry, H.M., Ahmed-Farid, O.A., Hegazy, S.M., Rezk, M.M.
    • Journal: Journal of Trace Elements in Medicine and Biology
    • Year: 2024
    • Volume: 81
    • Article Number: 127323
    • Citations: 2
  • Publication Title: Nanoliposomal amino acids counteracting protein malnutrition induced hematopoietic and hepatic complications
    • Authors: Ahmed, R.F., Elbaset, M.A., Farouk, H., Ahmed-Farid, O.A.H., Nasr, M.
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2023
    • Volume: 89
    • Article Number: 105051
    • Citations: 0

 

Rashna Mirza | Pharmaceutical Science | Best Researcher Award

Published on by World Science Awards

Ms. Rashna Mirza | Pharmaceutical Science | Best Researcher Award

PhD scholar of Quaid-i-Azam University, Pakistan.

Rashna Mirza is a distinguished researcher currently pursuing a PhD at Quaid-i-Azam University, Islamabad, focusing on advanced drug delivery systems, including brain-targeted transfersomes and optimized nano-transfersomes. A Gold Medalist in Pharm D from People’s University of Medical and Health Sciences for Women, she has demonstrated exceptional academic and research prowess. Her professional experience includes roles in quality assurance, pharmaceutical research, and laboratory supervision, showcasing her expertise in drug formulation and optimization. Rashna’s commitment to the field is reflected in her impactful publications and active participation in conferences. Her strengths lie in cutting-edge research, scientific communication, and organizational skills, though expanding her research impact and gaining leadership experience could further enhance her profile. Rashna’s background and achievements make her a strong candidate for the Research for Best Researcher Award.

Profile

Education

Rashna Mirza’s educational background reflects her strong commitment to the field of pharmaceutics. She is currently pursuing a PhD at Quaid-i-Azam University, Islamabad, with research focused on advanced drug delivery systems, including brain targeting of Cefepime-loaded transfersomes and optimization of nano-transfersomes for transdermal delivery. Prior to her PhD, Rashna completed her M.Phil at the same institution, where she continued to build on her expertise in pharmaceutics. She earned her Pharm D from People’s University of Medical and Health Sciences for Women, where she graduated as a Gold Medalist, underscoring her exceptional academic performance. Rashna’s foundational education includes an FSC Pre-Medical from Government Girls Degree College, Islamabad, and matriculation from Foundation Public School, Karachi. This robust educational background has equipped her with a deep understanding of pharmaceutical sciences and a solid foundation for her research career.

Professional Experience

Rashna Mirza has a diverse professional background that underscores her expertise in pharmaceutics and drug development. Currently pursuing her PhD at Quaid-i-Azam University, she is engaged in pioneering research on brain-targeted drug delivery systems and transdermal gels. Her experience includes working as a Lab Demonstrator at Quaid-i-Azam University, where she managed laboratory work, supervised experiments, and facilitated instructional activities. She also served as a Quality Assurance Inspector at Herbiotics, where she conducted inspections, quality audits, and process monitoring. Additionally, Rashna worked as a Retail Pharmacist at Punjab Pharmacy, handling inventory management, patient counseling, and medication therapy management. Her academic journey is marked by her gold medal achievement in Pharm D from People’s University of Medical and Health Sciences for Women. Her professional roles reflect her strong organizational, supervisory, and research skills, contributing significantly to her field.

Research Interest

Rashna Mirza’s research interests center on the development and optimization of novel drug delivery systems to enhance therapeutic outcomes. Her current PhD research focuses on innovative approaches such as brain-targeting of Cefepime-loaded transfersomes and the formulation of nano-transfersomes-based chitosan gels for transdermal delivery. This work aims to improve drug efficacy and patient compliance through advanced delivery mechanisms. Rashna is also interested in the formulation and optimization of thermosensitive in situ gels, exploring their potential for controlled and targeted drug release. Her research integrates both in vitro and in vivo studies to address challenges in pharmaceutical science, emphasizing the importance of precise drug delivery for effective treatment. Rashna’s work is characterized by a commitment to advancing pharmaceutics through rigorous experimentation and collaboration, contributing valuable insights to the field and aiming to bridge gaps in current drug delivery technologies.

Research Skills

Rashna Mirza exhibits a strong suite of research skills that underscore her capabilities in advancing the field of pharmaceutics. Her expertise in drug formulation and optimization is evident through her current PhD research, which involves innovative drug delivery systems such as brain-targeting transfersomes and nano-transfersomes. Rashna’s proficiency in statistical design and optimization further enhances her ability to develop and refine novel drug delivery methods. Her hands-on laboratory skills are complemented by her experience in quality assurance and process monitoring, ensuring meticulous evaluation and control of research processes. Additionally, Rashna’s solid background in scientific communication and report writing enables her to effectively present and disseminate research findings. Her involvement in interdisciplinary collaboration and active participation in conferences reflects her commitment to integrating diverse perspectives and advancing scientific knowledge. Overall, Rashna’s research skills demonstrate a well-rounded and impactful approach to pharmaceutics and drug development.

Award and Recognition

Rashna Mirza, a distinguished researcher and Gold Medalist in Pharm D, has garnered significant recognition for her contributions to the field of pharmaceutics. Her innovative research on drug delivery systems, including brain-targeting transfersomes and nano-transfersome optimization, has been widely acknowledged within the scientific community. Rashna’s work is prominently featured in impactful publications, reflecting her dedication to advancing drug formulation and optimization. Her role as a Lab Demonstrator and Quality Assurance Inspector highlights her exceptional skills in scientific communication, process improvement, and interdisciplinary collaboration. Additionally, Rashna’s participation in notable conferences and her involvement in quality audits further underscore her commitment to excellence in pharmaceutical research. These achievements collectively affirm her as a leading figure in her field, earning her well-deserved recognition and positioning her as a promising candidate for prestigious awards in pharmaceutics and drug development.

Conclusion

Rashna Mirza’s strong background in pharmaceutics, demonstrated research capabilities, and commitment to advancing drug delivery systems position her as a suitable candidate for the Research for Best Researcher Award. Her strengths in innovative research, academic excellence, and effective communication support her candidacy, while opportunities for broader impact and leadership development could further enhance her profile.

Publication Top Notes

  • Brain targeting of cefepime loaded transfersomes based thermosensitive in situ gel via intranasal delivery: In vitro and in vivo studies
    • Authors: R. Mirza, A.U. Khan, K.U. Shah, F. Alasmari, Z. Hafeez
    • Year: 2024
    • Citations: 1
  • Statistical design and optimization of nano-transfersomes based chitosan gel for transdermal delivery of cefepime
    • Authors: R. Mirza, K.U. Shah, A.U. Khan, Z. Hafeez, S.U. Haq
    • Year: 2024